AAAAAA

   
Results: 1-13 |
Results: 13

Authors: ALJEHANI RM JEYARAJAH AR HAGEN B HOGDALL EV ORAM DH JACOBS IJ
Citation: Rm. Aljehani et al., MODEL FOR THE MOLECULAR-GENETIC DIAGNOSIS OF ENDOMETRIAL CANCER USINGK-RAS MUTATION ANALYSIS, Journal of the National Cancer Institute, 90(7), 1998, pp. 540-542

Authors: SHEPHERD JH CRAWFORD RAF ORAM DH
Citation: Jh. Shepherd et al., RADICAL TRACHELECTOMY - A WAY TO PRESERVE FERTILITY IN THE TREATMENT OF EARLY CERVICAL-CANCER, British journal of obstetrics and gynaecology, 105(8), 1998, pp. 912-916

Authors: WOOLAS RP ORAM DH BROWN CL JACOBS IJ
Citation: Rp. Woolas et al., PRIMARY-CARCINOMA OF THE PELVIC PERITONEUM INTERCEPTED BY SCREENING FOR OVARIAN-CANCER, International journal of gynecological cancer, 7(3), 1997, pp. 245-247

Authors: WOOLAS RP ORAM DH PRYSDAVIES A LEAKE J BROWN CL JACOBS IJ
Citation: Rp. Woolas et al., CA125 EXPRESSION AT CLINICAL-DIAGNOSIS BY OVARIAN-CARCINOMA NOT DETECTED THROUGH ANTECEDENT SERUM CA125 SCREENING, International journal of gynecological cancer, 6(2), 1996, pp. 98-101

Authors: JACOBS IJ SKATES S DAVIES AP WOOLAS RP JEYERAJAH A WEIDEMANN P SIBLEY K ORAM DH
Citation: Ij. Jacobs et al., RISK OF DIAGNOSIS OF OVARIAN-CANCER AFTER RAISED SERUM CA-125 CONCENTRATION - A PROSPECTIVE COHORT STUDY, BMJ. British medical journal, 313(7069), 1996, pp. 1355-1358

Authors: JEYARAJAH AR GALLAGHER CJ BLAKE PR ORAM DH DOWSETT M FISHER C OLIVER RTD
Citation: Ar. Jeyarajah et al., LONG-TERM FOLLOW-UP OF GONADOTROPIN-RELEASING-HORMONE ANALOG TREATMENT FOR RECURRENT ENDOMETRIAL CANCER, Gynecologic oncology, 63(1), 1996, pp. 47-52

Authors: GALLAGHER CJ ORAM DH JEYARAJAH AR OLIVER RTD BLAKE P SLEVIN M
Citation: Cj. Gallagher et al., GONADOTROPIN-RELEASING-HORMONE ANALOGUE(GNRHA) TREATMENT FOR RECURRENT PROGESTAGEN RESISTANT ENDOMETRIAL CANCER, British Journal of Cancer, 74, 1996, pp. 16-16

Authors: WOOLAS RP CONAWAY MR XU FJ JACOBS IJ YU YH DALY L DAVIES AP OBRIANT K BERCHUCK A SOPER JT CLARKEPEARSON DL RODRIGUEZ G ORAM DH BAST RC
Citation: Rp. Woolas et al., COMBINATIONS OF MULTIPLE SERUM MARKERS ARE SUPERIOR TO INDIVIDUAL ASSAYS FOR DISCRIMINATING MALIGNANT FROM BENIGN PELVIC MASSES, Gynecologic oncology, 59(1), 1995, pp. 111-116

Authors: LEAKE J WOOLAS RP DANIEL J ORAM DH BROWN CL
Citation: J. Leake et al., IMMUNOCYTOCHEMICAL AND SEROLOGICAL EXPRESSION OF CA 125 - A CLINICOPATHOLOGICAL STUDY OF 40 MALIGNANT OVARIAN EPITHELIAL TUMORS, Histopathology, 24(1), 1994, pp. 57-64

Authors: ORAM DH JEYARAJAH AR
Citation: Dh. Oram et Ar. Jeyarajah, THE ROLE OF ULTRASOUND AND TUMOR-MARKERS IN THE EARLY DETECTION OF OVARIAN-CANCER, British journal of obstetrics and gynaecology, 101(11), 1994, pp. 939-945

Authors: NORMANTAYLOR JQ WOOLAS RP ORAM DH GRUDZINSKAS JG
Citation: Jq. Normantaylor et al., SERUM CA-125 IN A PREGNANCY GENERATED BY OVUM DONATION, Human reproduction, 9(1), 1994, pp. 147-148

Authors: WOOLAS RP XU FJ JACOBS IJ YU YH DALY L BERCHUCK A SOPER JT CLARKEPEARSON DL ORAM DH BAST RC
Citation: Rp. Woolas et al., ELEVATION OF MULTIPLE SERUM MARKERS IN PATIENTS WITH STATE-I OVARIAN-CANCER, Journal of the National Cancer Institute, 85(21), 1993, pp. 1748-1751

Authors: JACOBS IJ RIVERA H ORAM DH BAST RC
Citation: Ij. Jacobs et al., DIFFERENTIAL-DIAGNOSIS OF OVARIAN-CANCER WITH TUMOR-MARKERS CA 125, CA 15-3 AND TAG 72-CENTER-DOT-3, British journal of obstetrics and gynaecology, 100(12), 1993, pp. 1120-1124
Risultati: 1-13 |